Full Text View
Tabular View
No Study Results Posted
Related Studies
Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back Pain
This study has been completed.
Study NCT00490919   Information provided by Purdue Pharma LP
First Received: June 21, 2007   Last Updated: November 19, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Low Back Pain
Additional conditions recognized in this trial
Back Pain
More general conditions related to this trial
Nervous System Diseases
Neurologic Manifestations
Pain
Signs and Symptoms
Interventions listed in this trial
Placebo
Additional drug interventions recognized in this trial
Buprenorphine
More general drug interventions related to this trial
Analgesics
Analgesics, Opioid
Central Nervous System Agents
Central Nervous System Depressants
Narcotic Antagonists
Narcotics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Purdue Pharma LP


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services